PER Spectives
/
Part 1 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with Dara Aisner MD, PhD
Our original embed player - you can use this to maintain continuity with any other episodes you've already embedded. Otherwise we'd suggest
upgrading to our new player.